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The widespread use of synthetic chemicals
after the Second World War has revolution-
ized agricultural practice. Initial studies of the
possible health effects of these substances on
humans were small and reassuring (Cameron
and Burgess 1945; Hayes and Durham 1956).
During the 1960s, however, it became evident
that persistent pesticides were having an
adverse impact on ecologic communities
(Ramade 1987; Ratcliffe 1970). This led to a
number of more extensive epidemiologic
investigations exploring the possible impact of
these exposures on human health [International
Agency for Research on Cancer (IARC) 1991;
Pearce and Reif 1990). These studies faced
numerous methodologic problems common
to environmental epidemiology, and even
today, our understanding of the relationship
between pesticides and human health is lim-
ited (Blondell 1990).
In this paper we describe a historical
cohort study undertaken to examine the health
outcomes of a group of agricultural workers
with high occupational pesticide exposures.
The main group investigated in this study
comprised all identifiable field staff employed
by the New South Wales (NSW), Australia,
Board of Tick Control between 1935 and
1995. The board constructed and operated
over 1,600 cattle dips in a tick quarantine zone
on the east coast of Australia, and over 3,000
staff worked on the program during the study
period. Subjects interviewed during the course
of the study report extremely high and recur-
rent exposures to the insecticides used in the
dips. This is supported by limited evidence
from an occupational monitoring program.
Methods
Identification of cohort. One of the method-
ologic challenges encountered by occupa-
tional cohort studies is the “healthy worker
effect,” characterized by a tendency for rela-
tively healthy individuals to be more likely to
gain employment and remain employed
(Breslow and Day 1987). This may poten-
tially bias studies toward finding lower mor-
tality rates in an occupational cohort when
compared with the general community and
thus mask true increases in mortality. To deal
with this problem, our study was designed to
allow comparison of the exposed group with
two reference populations: the Australian
population as a whole, and a control group of
outdoor workers drawn from a similar socioe-
conomic background but not occupationally
exposed to insecticides.
The study population comprised a dynamic
cohort divided into exposed and control sub-
cohorts. To facilitate matching with death
registries, the cohort was restricted to male
workers with known dates of birth. 
The exposed subcohort was made up of
all male staff identified by a search of NSW
government records as having worked as field
officers or laboratory staff for the NSW Board
of Tick Control at any time since 1935. A
total of 1,999 subjects met these criteria.
The control subcohort was made up of all
male staff identified by local governments
from the same region as having worked as out-
door field officers at any time since 1935. A
small group of office staff who had worked for
the Board of Tick Control were also included
in this group. A total of 1,984 subjects met
these criteria.
Subjects were followed from 1 January
1935, or their subsequent entry to the study,
until their death, loss to follow-up, or study
completion on 1 January 1996.
Ascertainment of vital status. Vital status
was ascertained by matching the cohort with
national death registers and health insurance
records. This matching was generally under-
taken using probabilistic record linkage.
Australian citizens are required to register
with the Australian Health Insurance
Commission to receive a universal health care
rebate (Medicare). Medicare commenced
operation in October 1983, and the cohort
was matched with commission records for
registration at any time after this date.
Subjects with current Medicare registration
were considered alive. The cohort was also
matched with the Australian National Deaths
Index (operating from 1980) and with the
NSW and Queensland Deaths Registers for
1945–1979.
Survey of surviving cohort members. We
also attempted to locate all cohort members
who were thought to still be alive. Possible
contact addresses were found for a total of
1,533 subjects, who were sent a questionnaire
by mail. Questions focused on factors that
might potentially confound the broader study,
such as smoking or alcohol consumption, pes-
ticide exposure history, a validated neuropsy-
chologic score, and a range of nonfatal
outcomes that may potentially be related to
pesticide exposure.
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We compared mortality of 1,999 outdoor staff working as part of an insecticide application pro-
gram during 1935–1996 with that of 1,984 outdoor workers not occupationally exposed to insec-
ticides, and with the Australian population. Surviving subjects also completed a morbidity
questionnaire. Mortality was significantly higher in both exposed and control subjects compared
with the Australian population. The major cause was mortality from smoking-related diseases.
Mortality was also significantly increased in exposed subjects for a number of conditions that do
not appear to be the result of smoking patterns. Compared with the general Australian popula-
tion, mortality over the total study period was increased for asthma [standardized mortality ratio
(SMR) = 3.45; 95% confidence interval (CI), 1.39–7.10] and for diabetes (SMR = 3.57; 95% CI,
1.16–8.32 for subjects working < 5 years). Mortality from pancreatic cancer was more frequent in
subjects exposed to 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (SMR = 5.27; 95% CI,
1.09–15.40 for subjects working < 3 years). Compared with the control population, mortality
from leukemia was increased in subjects working with more modern chemicals (standardized inci-
dence ratio = 20.90; 95% CI, 1.54–284.41 for myeloid leukemia in the highest exposure group).
There was also an increase in self-reported chronic illness and asthma, and lower neuropsychologic
functioning scores among surviving exposed subjects when compared with controls. Diabetes was
reported more commonly by subjects reporting occupational use of herbicides. These findings
lend weight to other studies suggesting an association between adverse health effects and exposure
to pesticides. Key words: asthma, cohort study, DDT, diabetes, leukemia, neoplasms, pancreatic
cancer, pesticides. Environ Health Perspect 111:724–730 (2003). doi:10.1289/ehp.5885 available
via http://dx.doi.org/ [Online 30 October 2002]
Analytical methods. To compare the
exposed subcohort with the general Australian
population, we calculated standardized mor-
tality ratios (SMRs) using person-years analy-
sis, based on a published model allowing
stratification by year at risk, length of follow-
up, age at risk, and cumulative duration of
employment (Pearce and Checkoway 1987).
Exact Poisson 95% confidence intervals (CIs)
were estimated around these SMRs.
A range of models was used for this analy-
sis. The default model followed all subjects
from 1935 to 1995 inclusive, incorporating a
lag period of 10 years and excluded all sub-
jects for whom complete information was not
available. 
We also employed a person-years method,
using Poisson regression, to calculate stan-
dardized incidence ratios (SIRs) to compare
deaths in the exposed subcohort, or its differ-
ent exposure subgroups, with deaths in the
control subcohort. To allow for the sampling
variability resulting from small numbers in
the denominator, CIs were calculated using
likelihood ratio-based methods, considered to
be more robust than classical approaches
when the sample size is small (Venzon and
Moogavcar 1988). 
Questions in the survey distributed to sur-
viving cohort members were analyzed using
logistic regression. The model included log of
subject age and was adjusted for possible 
confounding from smoking. For analysis of
continuous outcome variables, we used analy-
sis of variance, adjusting for age. 
Exposure assessment. Board of Tick
Control records indicate that chemical usage
followed defined patterns over the study
period (Table 1). For the purposes of analysis,
these periods were categorized into periods of
arsenic use (1935–1955), 1,1,1-trichloro-2,2-
bis(p-chlorophenyl)ethane (DDT) use
(1955–1962), and modern chemical use
(1963–1996). The number of subjects work-
ing during each exposure period is shown in
Table 2.
A subject’s period of employment was used
to estimate both the type of chemical he was
likely to have been exposed to and the dura-
tion of this exposure. This was categorized into
exposure groups: “All” equates to any employ-
ment during a particular period, “Dose 0”
relates to exposed subjects not yet past 10 year
exposure lag, “Dose 1” equates to < 5 years
employment, “Dose 2” equates to ≥ 5 to < 15
years of employment, and “Dose 3” equates to
≥ 15 years of employment. For the DDT
period, “Dose 1” represents < 3 years and
“Dose 2” represents ≥ 3 years of employment. 
Results
Results of an occupational monitoring pro-
gram undertaken during the early 1980s by
the NSW Health Department support subject
reports of high occupational pesticide expo-
sure. Sampling in that program included total
serum DDT levels. Although DDT use had
stopped at least 18 years before this sampling
period, DDT has a long half-life in humans,
and the DDT metabolite DDE (1,1,dichloro-
2,2-bis(p-chlorophenyl)ethylene; included in
total DDT results) is a good indicator of past
exposure (Mussalo-Rauhamaa 1991). The
total serum DDT levels of cohort members
are shown in Table 3. Only three exposed
subjects who had worked during the DDT era
could be matched with subjects in the sam-
pling program. However, the serum mean
level in these three DDT-exposed subjects was
over five times that of the 14 matched mem-
bers of the control subcohort and eight times
that of the 8 exposed subjects who did not
work during the DDT era.
Subjects in the exposed subcohort who
responded to the study survey were also sig-
nificantly more likely to report using pesti-
cides occupationally [odds ratio (OR) =
10.39; 95% CI, 6.15–17.54]. 
Exposed and control subjects did, how-
ever, offer similar survey responses on key
lifestyle indicators, suggesting they were drawn
from comparable populations (Table 4). The
average years at school was significantly differ-
ent (p < 0.01), but this value was only 0.4
years. When age-adjusted responses were com-
pared using logistic regression, there was no
significant difference between either current
smoking or alcohol consumption patterns.
Respondents from the exposed subcohort
were, however, significantly more likely to
report ever having smoked (OR = 1.66; 95%
CI, 1.21–2.28). 
Table 5 illustrates the determination of vital
status for cohort members. Of the 3,983 cohort
members, 2,913 enrolled with Medicare after
its commencement in 1983. Enrollment
ceased for 337 of these subjects, and death
certificates were found for 328 of these, leaving
9 lost to follow-up. 
A further 1,070 subjects never enrolled
with Medicare. Employment records indicate
that 154 of these subjects were alive after
1983, and they were considered to have cho-
sen not to enroll or to have escaped matching.
For analysis, these subjects were considered
alive until their last contact with the study.
Of the remaining subjects who never enrolled
with Medicare, there were 666 death register
matches. The remaining 261 subjects were
considered to have been lost to follow-up,
giving a total of 270 (6.8%) subjects lost to
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Table 1. Chemicals used in cattle dips during differ-
ent periods and the classification used in this study. 
Tickicide Period of use
Period of arsenic use 
Arsenic (trioxide) 1935–1955
Period of DDT use 
DDT 1955–1962
Benzene hexachloride 1955–1962

















Table 2. Number of subjects working during different chemical periods.
No. of subjects 
Period Working exclusively during this period Working at all during this period
Arsenic use 5 (1 control, 4 exposed) 528 (199 controls, 329 exposed)
DDT use 144 (24 controls, 120 exposed) 579 (185 controls, 394 exposed)
Modern chemical use 2,100 (1,257 controls, 843 exposed) 2,949 (1,586 controls, 1,363 exposed)
Table 3. Results of biological monitoring for DDT of
study subjects, 1980–1987.
Serum DDT
No. Mean total (ppb) Range
Controls 14 6.7 0–14
DDT-exposed 3 39.3 10, 28, 80a
subjects
Other exposed 8 4.25 0–11
subjects
aActual results for three subjects.
Table 4. Odds of self-reported behaviors in exposed
subjects compared with controls.
OR 95% LCL 95% UCL
Ever drinker 1.47 0.85 2.54
Current smoker 1.16 0.80 1.68
Ever smoker 1.66* 1.21 2.28
Abbreviations: LCL, lower confidence limit; UCL, upper
confidence limit. 
*Significant at p < 0.05.
Table 5. Vital status by exposure group.a
Exposed Controls
Total subjects 1,999 1,984
Medicare match 1,353 1,560
Medicare enrollment ended 204 133
Death register match 776 392
Lost to follow-up 145 125
aNumbers do not add up because some subjects were
matched with death registry before Medicare enrollment
ceased.
follow-up. Vital status ascertainment for the
study is therefore estimated at 93.2%, a figure
considered acceptable in large cohort studies
(Checkoway et al. 1989). 
The initial response to the questionnaire
mailout was poor. Nonresponding subjects
were then followed up by telephone. The total
response rate for the questionnaire was 54.9%,
with a further 17% choosing the option of
returning a blank questionnaire. The percent-
age of exposed subjects and controls choosing
to return a blank questionnaire was almost
identical. However, exposed subjects (60.9%)
were more likely to respond than controls
(51.6%), and this difference was significant
after adjusting for age using Mantel-Haenszel
analysis (p < 0.001). Because a large proportion
of the subjects failing to return a questionnaire
could also not be contacted by phone, the low
response rate may largely reflect incorrect con-
tact addresses. A total of 1,167 (391 control,
776 exposed) deaths were identified among
cohort members.
Outcomes with significant results in SMR
and SIR analysis using the default model are
shown in Tables 6 and 7, and these findings
are expanded on in the “Discussion.”
Significant increases in mortality were identi-
fied in at least one exposure group for total
deaths, asthma, diabetes, ischemic heart 
disease, respiratory disease, total cancers, pan-
creatic cancer, and leukemias. There were no
significant increases in SMR or SIR in any
exposure group for cancers of the bladder,
brain, colon, prostate, lung, rectum, or stom-
ach, nor for melanoma, multiple myeloma,
non-Hodgkin lymphoma (NHL), or emphy-
sema (Table 8). There was no significant
change in SMR for circulatory disease,
although the most exposed group working
during the arsenic period showed an
increased SIR. Full results of analysis are
available on request from the authors.
Numerous other analyses were under-
taken using different models such as varying
Environmental Medicine | Beard et al.
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Table 6. Significant SMRs of subjects compared with the Australian population (adjusted for age and period of follow-up).
All chemical periods Arsenic period DDT period Modern chemical period
Exposure group OBS SMR LCL UCL SMR LCL UCL SMR LCL UCL SMR LCL UCL
All deaths
Controls 331 1.08 0.96 1.22 1.00 0.81 1.23 1.07 0.92 1.24 1.24* 1.01 1.50
All 607 1.10* 1.01 1.20 0.97 0.83 1.12 1.09 0.98 1.20 1.28* 1.06 1.53
Dose 0 72 1.00 0.78 1.26
Dose 1 104 1.03 0.84 1.24 1.00 0.75 1.30 1.03 0.78 1.33 1.09 0.81 1.44
Dose 2 177 1.04 0.90 1.21 0.80 0.60 1.04 1.10 0.98 1.23 1.39* 1.07 1.77
Dose 3 228 1.19 1.04 1.35 1.16 0.89 1.49 2.13 0.97 4.04
Asthma
Controls 2 1.61 0.19 5.81 0.00 0.00 7.48 1.40 0.04 7.81 2.22 0.06 12.37
All 7 3.45* 1.39 7.10 3.94 0.81 11.51 2.27 0.47 6.64 6.44* 1.33 18.82
Dose 1 2 3.87 0.47 14.00 3.61 0.09 20.09 0.00 0.00 12.11 4.36 0.11 24.31
Dose 2 3 3.89 0.80 11.38 6.09 0.74 21.99 2.80 0.58 8.17 9.31* 1.13 33.62
Dose 3 2 2.69 0.33 9.71 0.00 0.00 19.23 0.00 0.00 136.9
Diabetes
Controls 2 0.52 0.06 1.87 0.85 0.02 4.73 0.40 0.01 2.21 0.77 0.02 4.31
All 12 1.49 0.71 2.74 0.85 0.02 4.73 1.22 0.45 2.65 2.70 0.74 6.91
Dose 1 5 3.57* 1.16 8.32 1.47 0.04 8.18 1.30 0.03 7.26 2.96 0.36 10.71
Dose 2 4 1.66 0.45 4.26 0.00 0.00 3.43 1.20 0.39 2.80 2.76 0.33 9.95
Dose 3 1 0.34 0.00 1.92 0.00 0.00 4.18 0.00 0.00 36.71
Ischemic heart disease
Controls 115 1.38* 1.13 1.68 1.80* 1.29 2.45 1.38* 1.08 1.74 1.31 0.91 1.83
All 205 1.37* 1.18 1.59 1.36* 1.02 1.78 1.31* 1.09 1.56 1.28 0.91 1.76
Dose 1 43 1.70* 1.24 2.29 0.85 0.44 1.48 2.09* 1.37 3.07 1.32 0.79 2.06
Dose 2 57 1.25 0.95 1.62 1.56 0.98 2.37 1.20 0.98 1.45 1.14 0.65 1.85
Dose 3 71 1.32* 1.03 1.66 1.79* 1.07 2.79 2.55 0.53 7.46
Respiratory disease
Controls 33 1.50* 1.02 2.12 1.29 0.59 2.44 1.43 0.87 2.21 1.92 0.99 3.36
All 72 1.61* 1.24 2.07 1.72* 1.10 2.55 1.60* 1.16 2.13 1.87* 1.02 3.14
Dose 1 8 1.09 0.47 2.14 2.36* 1.08 4.49 0.45 0.06 1.64 1.52 0.49 3.54
Dose 2 19 1.39 0.84 2.17 1.67 0.76 3.17 1.81* 1.31 2.43 1.83 0.73 3.76
Dose 3 34 2.03* 1.41 2.84 1.25 0.46 2.73 5.68 0.69 20.52
All cancer
Controls 85 1.07 0.83 1.35 1.01 0.61 1.57 1.01 0.73 1.38 1.30 0.88 1.84
All 148 1.18 0.99 1.41 1.01 0.70 1.40 1.15 0.92 1.42 1.29 0.89 1.80
Dose 1 26 1.06 0.69 1.56 1.16 0.64 1.95 1.07 0.57 1.83 1.21 0.68 1.99
Dose 2 43 1.12 0.81 1.51 0.66 0.30 1.26 1.16 0.92 1.46 1.20 0.67 1.97
Dose 3 59 1.30 0.99 1.68 1.31 0.68 2.29 2.75 0.75 7.03
Pancreatic cancer
Controls 2 0.67 0.08 2.41 0.00 0.00 3.25 0.54 0.01 2.99 0.94 0.02 5.22
All 8 1.61 0.69 3.16 1.78 0.37 5.19 1.98 0.79 4.07 0.00 0.00 2.53
Dose 1 1 0.88 0.02 4.91 3.39 0.41 12.23 5.27* 1.09 15.40 0.00 0.00 5.26
Dose 2 2 1.12 0.14 4.05 0.00 0.00 4.51 1.35 0.37 3.44 0.00 0.00 5.45
Dose 3 5 2.43 0.79 5.66 2.30 0.06 12.83 0.00 0.00 47.70
Leukemia (all types)
Controls 4 1.93 0.53 4.94 1.69 0.04 9.39 1.61 0.19 5.80 2.61 0.32 9.44
All 7 1.79 0.66 3.89 0.92 0.02 5.11 1.69 0.46 4.34 3.70 0.76 10.81
Dose 1 2 2.51 0.30 9.08 2.59 0.07 14.43 2.57 0.06 14.29 5.20 0.63 18.79
Dose 2 1 0.83 0.02 4.61 0.00 0.00 7.08 1.52 0.31 4.45 0.00 0.00 7.82
Dose 3 3 2.22 0.46 6.48 0.00 0.00 10.71 22.89 0.58 127.53
Abbreviations: LCL, lower confidence limit; OBS, number of deaths observed; UCL, upper confidence limit.
*Significant at p < 0.05.
the exposure lag or using an average duration
of employment to include subjects without a
known final date of employment. In general,
these made little difference in the study find-
ings. One notable exception was removing
the exposure lag for analysis of leukemia.
When the exposure lag was removed, the
SMR for leukemia in exposed subjects work-
ing during the modern chemical period was
of borderline significance (SMR = 3.62; 95%
CI, 0.99–9.26), and the SMR for the lowest
exposure group became statistically significant
(SMR = 6.41; 95% CI, 1.32–18.73).
Default analysis of the modern chemical
period excluded subjects who had worked at
other times in the study. Using this approach,
there was only a small increase in mortality
from NHL. When subjects who had also
worked in other periods were included in the
analysis, both the SMR and lower confidence
limit for NHL increased (SMR = 2.22; 95%
CI, 0.72–5.18). When NHL mortality among
this group was compared with controls, the
increase in SIR for all exposed subjects was of
borderline significance (SIR = 8.71; 95% CI,
0.97–78.12), and this was statistically signifi-
cant for exposed subjects working 5–15 years
(SIR = 11.60; 95% CI, 1.11–121.74).
Results of comparisons of self-reported
morbidity between the exposed and control
subcohorts after adjusting for age and smok-
ing are shown in Table 9. Because a number
of control subjects reported occupational use
of herbicides, morbidity was also compared by
subject’s reported herbicide exposure. Subjects
reporting herbicide use had significantly
increased odds for diabetes (OR =  2.26; 95%
CI, 1.15–4.43) and hay fever (OR = 1.82;
95% CI, 1.23–2.69) after adjusting for age
and smoking status. 
Discussion
Methodologically, this study has a number of
strengths. The study is of a moderately sized
cohort followed over a prolonged period (over
82,000 person-years of follow-up), with good
outcome ascertainment. The healthy worker
effect also appears to have been largely over-
come by the study’s long follow-up period.
Including a control group allows some
assessment of the degree of confounding by
smoking and other lifestyle factors on the
cohort outcomes. Although these two sub-
cohorts were not drawn from the same
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Table 7. SIRs of mortality in exposed subjects and controls by exposure group (adjusted for log age).a
All periods Arsenic period DDT period Modern period 
Dose SIR LCL UCL SIR LCL UCL SIR LCL UCL SIR LCL UCL
All deaths
All 1.13 0.98 1.30 1.11 0.94 1.32 1.17* 1.01 1.36 1.14 0.89 1.45
Dose 1 0.96 0.77 1.20 1.07 0.85 1.35 1.10 0.83 1.45 0.93 0.67 1.28
Dose 2 1.12 0.93 1.35 0.96 0.74 1.23 1.18* 1.01 1.38 1.34 0.98 1.81
Dose 3 1.25* 1.05 1.49 1.53* 1.16 2.02 1.65 0.84 3.25
Asthma
All 3.09 0.62 15.52 2.79 0.44 17.72 1.62 0.30 8.85 4.38 0.42 45.78
Dose 1 3.16 0.44 22.45 – – – – – – 3.05 0.18 50.38
Dose 2 3.53 0.57 21.81 – – – – – – 6.71 0.52 86.70
Dose 3 2.46 0.31 19.23 – – – 0.00 0.00
Diabetes
All 3.95 0.84 18.44 0.91 0.08 10.61 4.88 0.90 26.45 4.71 0.50 44.44
Dose 1 7.68* 1.49 39.61 – – – 4.51 0.40 51.31 – – –
Dose 2 4.06 0.74 22.42 – – – 4.98 0.87 28.36 – – –
Dose 3 0.93 0.08 10.52 – – – – – –
Circulatory disease
All 1.08 0.89 1.32 1.09 0.86 1.39 1.16 0.94 1.43 0.98 0.68 1.42
Dose 1 0.99 0.73 1.34 0.91 0.64 1.29 1.18 0.81 1.73 0.90 0.56 1.44
Dose 2 1.08 0.84 1.40 0.92 0.65 1.32 1.15 0.92 1.44 1.07 0.67 1.70
Dose 3 1.13 0.89 1.45 1.82 1.27 2.60 1.08 0.34 3.44
All cancers
All 1.24 0.93 1.66 1.11 0.78 1.58 1.21 0.89 1.64 1.29 0.80 2.07
Dose 1 1.03 0.66 1.61 1.21 0.76 1.91 1.07 0.60 1.92 1.13 0.62 2.06
Dose 2 1.16 0.80 1.69 0.95 0.57 1.60 1.24 0.90 1.70 1.30 0.70 2.41
Dose 3 1.49* 1.05 2.13 1.21 0.65 2.26 2.94* 1.03 8.34
Leukemia 
All 1.24 0.36 4.29 – – – – – – 3.02 0.54 16.96
Dose 1 1.34 0.26 6.96 – – – – – – 3.33 0.52 21.38
Dose 2 0.57 0.06 5.02 – – – – – – – – –
Dose 3 2.06 0.43 9.92 – – – 27.44* 2.23 337.99
Lymphocytic leukemia
All 1.42 0.18 11.54 – – – 0.90 0.07 11.45 7.45 0.33 170.74
Dose 1 1.86 0.16 21.11 – – – – – – 9.74 0.46 205.45
Dose 2 1.79 0.14 22.14 – – – – – – – – –
Dose 3 – – – – – – – – –
Myeloid leukemia
All 1.15 0.25 5.39 0.60 0.06 6.05 1.64 0.30 8.98 1.94 0.25 15.39
Dose 1 1.15 0.12 11.21 1.62 0.16 15.83 2.99 0.30 29.76 1.83 0.16 21.13
Dose 2 0.00 0.00 – 0.00 0.00 – 1.32 0.20 8.69 – – –
Dose 3 3.92 0.65 23.63 0.00 0.00 – 20.90* 1.54 284.41
Pancreatic cancer
All 2.89 0.60 13.85 3.13 0.56 17.62 2.72 0.67 11.01 – – –
Dose 1 1.54 0.14 17.01 – – – 7.00* 1.39 35.32 – – –
Dose 2 2.07 0.29 14.93 – – – 1.82 0.39 8.49 – – –
Dose 3 4.79 0.86 26.59 – – – – – –
Abbreviations:  –, failure to converge; LCL, lower confidence limit; UCL, upper confidence limit.
aPoisson regression adjusting for log age with likelihood ratio confidence limits, 10-year exposure lag. For all deaths, analysis was also adjusted for whether the year of death occurred
before or after 1960. *Significant at p < 0.05.
occupational population, a range of evidence
suggests they shared similar but not identical
lifestyles. This includes their similar area of
residence, similarity of occupation, and self-
reported alcohol, smoking, and schooling
experience.
As with much environmental or occupa-
tional epidemiology, exposure assessment
remains a problem, although limited biological
monitoring supports assumptions about high
pesticide exposures in the exposed subgroup. A
number of pesticides were used during the
study period, and this allows for analysis of the
impact of specific chemicals in different peri-
ods. However, not all exposed subjects work-
ing at a particular point in time used the same
chemicals. This may mask true associations, as
the experience of subjects exposed to that
chemical are pooled with other exposed sub-
jects using different pesticides. 
Although it is common practice to use
duration of exposure as a surrogate for expo-
sure dose, it is also possible that the first years
of employment were periods of relatively high
exposure, as newly employed staff may have
been given the dirtiest jobs and were less
skilled at avoiding exposure. It is also possible
that staff with the most difficulty tolerating
these early high exposures, possibly due to
genetic variance in their ability to metabolize,
tend to leave employment after shorter peri-
ods. Such a trend has been identified in at
least one small study of genetic susceptibility
and has even been suggested as an explana-
tion for the healthy worker effect (Au et al.
1999). A number of positive associations
identified in this study were found in the
shortest exposure group.
This study also undertook a large number
of statistical analyses for a wide range of out-
comes. SMR and SIR analysis were under-
taken on over 20 separate conditions, with
further analysis of a number of separate expo-
sure groups and exposure periods for each
condition. This needs to be considered when
assessing the results as, by chance, a statisti-
cally significant result might be expected for
every 20 analyses. 
To avoid the risk that significant results
are simply a consequence of multiple compar-
isons, the study findings should be inter-
preted using a weight-of-evidence approach.
Factors that might add weight to a positive
finding include consistency in results from
both internal and external analysis, support-
ing evidence from the survey of surviving
cohort members, the size of the association,
the number of subjects involved, trends in
exposure categories, evidence from other
research, and whether the identified associa-
tion is physiologically plausible.
The identified increase in all-cause mortal-
ity in both exposed and nonexposed subco-
horts is somewhat surprising, given the general
experience in occupational studies of a healthy
worker effect—sometimes amplified in studies
on pesticides by the otherwise healthier
lifestyles of farmers (Alberghini et al. 1991).
The main cause of the increase in this study is
excess mortality from circulatory disease, res-
piratory disease, and lung cancer. 
There is considerable evidence to suggest
that these findings reflect smoking patterns in
both the exposed and control subcohorts.
Although some authors have suggested that
the potential confounding effect of smoking
is modest unless the smoking habits of a
study population are quite extreme (Blair et
al. 1988), a number of methods have been
proposed for assessing the impact of smoking
in epidemiologic research (Axelson and
Steenland 1988). If smoking rates are high, a
consistent increase in all smoking related dis-
eases might be expected. Not only is this the
case in this study, but the increase also occurs
across the total study period, arguing against
it being the result of a particular chemical
exposure. Deaths from smoking-related dis-
eases are also increased in the control subco-
hort and in exposed subjects not yet past the
10-year exposure lag. These disease patterns
suggest both subcohorts had increased smok-
ing rates compared with the Australian popu-
lation. This is supported by the lower,
nonsignificant incidence ratios when smok-
ing-related disease rates are compared between
the two groups. 
The increases in mortality from respira-
tory and ischemic heart disease observed in
this study are therefore likely to relate to
smoking patterns. However, it is unlikely that
smoking is also responsible for the identified
increases in mortality from two other smok-
ing-related diseases: pancreatic cancer and
asthma. This remains high when exposed
subjects are compared with controls, and
both SMRs and SIRs are clearly higher than
those for lung cancer, which is an indicator of
any difference in smoking habits between the
two compared subcohorts.
All exposed subjects dying from pancre-
atic cancer worked during the period of DDT
use, and mortality during this period was ele-
vated compared with both the Australian
population and controls. For those working
less than 3 years, this increase was statistically
significant compared with both controls and
the Australian population. 
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Table 8. Outcomes not reaching statistical significance: SMRs of exposed subjects compared with the
Australian population (adjusted for age and period of follow-up) and SIRs of mortality in exposed subjects
compared with controls adjusted for log age.
Disease EXP OBS SMR LCL UCL SIR LCL UCL
Emphysema 4.62 6 1.30 0.48 2.82 0.54 0.17 1.69
Bladder cancer 3.73 3 0.80 0.17 2.35 0.40 0.09 1.84
Brain cancer 3.30 3 0.91 0.19 2.65 3.13 0.29 33.43
Colon cancer 11.23 6 0.53 0.20 1.16 0.52 0.18 1.54
Lung cancer 37.24 49 1.32 0.97 1.74 1.15 0.72 1.83
Melanoma ND ND ND ND ND 0.62 0.10 3.72
Multiple myeloma ND ND ND ND ND 0.59 0.04 9.87
NHL 3.66 6 1.64 0.60 3.57 4.57 0.53 39.39
Prostate cancer 12.11 16 1.32 0.76 2.15 1.05 0.46 2.39
Rectal cancer 4.94 8 1.62 0.70 3.19 2.02 0.52 7.86
Stomach cancer 9.11 11 1.21 0.60 2.16 2.12 0.66 6.87
Abbreviations: EXP, number of deaths expected; LCL, lower confidence limit; ND, no Australian data; OBS, number of
deaths observed; UCL, upper confidence limit. Includes subjects employed at any time during this period. 
Table 9. ORs for self-reported outcomes in exposed subcohort compared with controls.a
Outcome Controls Exposed OR LCL UCL
Asthma 53 55 1.59* 1.05 2.43
Child with asthma 92 71 1.45* 1.01 2.09
Hay fever 93 56 0.98 0.67 1.45
Eczema/dermatitis 42 47 1.62* 1.02 2.56
Bronchitis 60 53 1.32 0.87 2.01
Emphysema 8 14 1.99 0.80 4.93
Skin cancer 259 168 0.86 0.64 1.16
Depressed 55 43 1.22 0.73 2.05
Birth defect 28 19 1.01 0.53 1.92
Difficulty achieving pregnancy 22 20 1.37 0.72 2.61
Miscarriage 90 74 1.40 0.98 2.00
Recurring ill health 21 35 2.73* 1.54 4.84
Chronic fatigue syndrome 8 12 2.66* 1.01 7.02
Diabetes 23 21 1.13 0.59 2.16
Arboviral infection 30 30 2.14* 1.21 3.78
Circulatory disease 95 83 1.23 0.86 1.75
Parkinson disease 1 2 3.30 0.28 38.94
Abbreviations: LCL, lower confidence limit; UCL, upper confidence limit. 
aLogistic regression by group (exposed subject or control) adjusted for log age, ever smoked. *Significant at p < 0.05.
Although DDT was first used in 1955, it
was introduced slowly into the dipping pro-
gram and was not used in the majority of dips
until 1961. This may have resulted in misclas-
sification bias toward the null, as in the early
years of the DDT period, many exposed sub-
jects may have used DDT infrequently, if at
all. If there was a true association between
DDT exposure and pancreatic cancer, it
might therefore be expected that this relation-
ship would be stronger for subjects working in
the later years of the DDT era, when exposure
to the chemical was more likely. Members of
the exposed subcohort working during the
later part of this period do show both
increased standardized mortality rates and
increasing lower confidence limits. However,
mortality rates still remain short of statistical
significance (for subjects working during
1962, SMR = 2.41; 95% CI, 0.89–5.25; SIR
= 4.73; 95% CI, 0.89–25.15). When exposed
subjects not yet past the 10-year exposure lag
were added to the control group to increase
study power, this increase is statistically signif-
icant (SIR = 6.44; 95% CI, 1.22–34.13).
These findings are consistent with a
causative association between DDT exposure
and pancreatic cancer and are consistent with
the results of other studies. There is, however,
still no general agreement on whether pesticides
as a whole, or DDT in particular, are associated
with pancreatic cancer (Garabrant et al. 1992;
Hoppin et al. 2000; Porta et al. 1999).
When compared with the Australian
population, members of the exposed group
working in the modern chemical period had
an increase in mortality from diabetes (type
unspecified) of borderline statistical signifi-
cance (SMR = 3.00; 95% CI, 0.97–7.00).
This association was statistically significant
when all exposure lag models other than the
10-year default used in analysis were applied.
For exposed subjects as a group working in
the early period of modern chemical use
(1963–1976), the increase was also significant
(SMR = 3.08; 95% CI, 1.00–7.20). There
was also significantly increased mortality from
diabetes for exposed subjects as a group over
the total study period in the < 5 years expo-
sure group, and this persisted when exposed
subject were compared with controls. There
were also large increases in mortality when
exposed subjects were compared with con-
trols over different chemical periods, particu-
larly the modern era, although none of these
were statistically significant.
Although the increased death rates from
diabetes are based on a total of only 14
deaths, a number of factors suggest this asso-
ciation may be real. Firstly, the association is
relatively large and seems to relate to a spe-
cific chemical period (post-1963), suggesting
a specific exposure during this time exerted an
effect. Mortality is not raised for the control
group, suggesting the outcome was not influ-
enced by an underlying lifestyle difference. A
true association is also supported by the find-
ing in the survey of surviving subjects of a
higher prevalence of diabetes among those
reporting herbicide use, although it is not
known what type of herbicides were used.
There is evidence from other studies that
supports a possible association between pesti-
cide exposure and diabetes. A study of veter-
ans of Operation Ranch Hand during the
Vietnam War found increased diabetes preva-
lence with increasing exposure to 2,3,7,8-
tetrachlorodibenzo-p-dioxin, a contaminant
of the herbicide Agent Orange (Henriksen et
al. 1997). Before 1980, a wide range of pesti-
cides were used by subjects of our own study,
including 2,4-D and 2,4,5-T, substances pre-
sent in Agent Orange. 
Little other research has been done on
diabetes and pesticides, although a 1967 study
of 59 highly exposed workers at the Montrose
chemical factory in the United States found
high DDT levels in fat and an 8.6% preva-
lence of diabetes (Laws et al. 1967). A study of
3,579 U.S. workers involved in the produc-
tion of DDT found increased mortality from
diabetes, but not in those thought to be
exposed to DDT (Wong et al. 1984). An early
cohort study of 2,620 pesticide-exposed work-
ers suggested a higher prevalence of diabetes in
subjects with high DDT levels, although the
study had a low response rate and may have
been subject to reporting bias (Morgan et al.
1980). Another study calculated proportion-
ate mortality ratios from 748 deaths among
corn wet-milling workers and found increased
mortality from diabetes and a 3-fold excess of
pancreatic cancer deaths among some workers
(Thomas et al. 1985).
Several case studies of diabetes induced by
pesticide poisoning have been reported
(Takahashi et al. 2000), and one study of 23
subjects admitted to an Indian intensive care
unit with carbamate or organophosphate poi-
soning found 69% of subjects demonstrated
transient glycosuria (Shobha and Prakash
2000).
Diabetes has also been suggested as a risk
factor for pancreatic cancer (Calle et al. 1998)
and is a well-known risk factor for circulatory
disease. Mortality from both these conditions
was elevated in this study. 
Although the findings of our study are not
conclusive, they are consistent with an increase
in diabetes prevalence and mortality as a result
of pesticide exposure. Whether this increase
relates to a particular chemical, class of chemi-
cals, or multiple chemical exposures is unclear.
On the other hand, the findings may simply
result from the large number of analyses
undertaken in this study. Diabetes warrants
further investigation as an outcome in studies
exploring the impact of pesticide exposure.
Evidence was also found for both increased
mortality from asthma and increased preva-
lence of atopic conditions among surviving
members of the exposed subcohort and their
offspring. Although it is possible mortality
ratios might be confounded by the influence of
smoking, mortality from asthma was also sig-
nificantly increased in exposed subjects when
they were compared with the control group,
suggesting the influence of smoking was lim-
ited. The association was not evenly distrib-
uted over the study period, suggesting it was
also not the result of other occupational expo-
sures such as cattle dander. Both asthma and
diabetes relate to immune function, and there
is some evidence this can be compromised by
pesticide exposure (Krzystyniak et al. 1995). 
Comparison of cohort mortality from
leukemia with the Australian population is
hampered by the lack of Australian data on
specific leukemia types for the majority of the
study period. The two main forms of
leukemia, lymphocytic and myeloid, may be
thought of as different diseases and are best
examined separately. If a toxic agent such as a
pesticide exerted its effect only on a specific
form of this disease, aggregating this informa-
tion would make it more difficult to identify
a real relationship.
We identified a nonsignificant increase in
SMR for leukemias as a group when exposed
subjects working during the era of modern
chemical use were compared with the
Australian population. When the exposure
lag was removed, this increase was of border-
line significance (SMR = 3.62; 95% CI,
0.99–9.26), and the SMR for the lowest
exposure group became statistically signifi-
cant (SMR = 6.41; 95% CI, 1.32–18.73).
There is considerable empirical and biologi-
cal logic for removing the lag period from
this analysis, as leukemia risks may rise soon
after leukemogenic exposure.
Mortality for subjects working during this
period was also increased compared with the
control group, and this increase was statisti-
cally significant for subjects in the highest
exposure category (SIR = 27.44; 95% CI,
2.23–337.99). Large SIRs were observed for
both lymphatic and myeloid leukemia, and
the increase in mortality for myeloid leukemia
was also statistically significant (SIR = 20.90;
95% CI, 1.54–284.41). There is a suggestion
of a dose–response relationship during this
period, with a tendency for mortality to be
higher in subjects working for longer terms. 
Several epidemiologic studies have sug-
gested an association between pesticide expo-
sure or farming and leukemia (Brown et al.
1990; Kristensen et al. 1996; Viel and
Richardson 1993). Increased mortality from
leukemia has also been identified in gardeners
(Hansen et al. 1992) and aerial pesticide
applicators (Cantor and Silberman 1999),
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suggesting the identified associations are not
the result of other farm-related exposures such
as bovine viruses. In our study, the increase in
mortality from leukemia across the different
chemical periods is uneven, also suggesting an
effect independent of bovine exposure. 
Our findings are based on a small number
of events in each leukemia category and may
simply reflect the multiple comparisons
undertaken during analysis. However, they
are also consistent with the relationship
between exposure to pesticides and leukemia
identified by other researchers.
The default analytical model also identi-
fied nonsignificant increases in mortality
from a number of other conditions previously
associated with pesticide exposure. These
include NHL, brain cancer, and prostate can-
cer. Failure to identify these increases as sig-
nificant may reflect the methodologic
limitations and power of the study, and the
findings do not conflict with the possibility
these may in fact be true associations.
Although the survey of surviving cohort
members identified possible associations
between several self-reported outcomes and
membership of the exposed subcohort,
methodologic limitations, including a low
response rate and the potential for recall bias,
limit the weight that can be put on this evi-
dence. Possible associations identified in the
survey included neuropsychologic dysfunc-
tion, chronic fatigue syndrome, and atopic
conditions.
In conclusion, this study identifies associ-
ations between a number of adverse outcomes
and pesticide exposure. These findings war-
rant further investigation and reinforce the
need to minimize exposure to pesticides in
both occupational settings and the broader
environment.
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